<DOC>
<DOCNO>
EP-0009155
</DOCNO>
<TEXT>
<DATE>
19800402
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/519 A61P-37/00 A61P-31/00 A61P-37/06 C07D-473/00 A61K-31/522 A61P-31/12 C07D-473/30 A61P-37/04 <main>C07D-473/30</main> A61K-31/52 A61P-35/00 A61P-37/02 
</IPC-CLASSIFICATIONS>
<TITLE>
9-hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients.
</TITLE>
<APPLICANT>
newport pharmaceuticalsus<sep>sloan kettering inst cancerus<sep>newport pharmaceuticals international, inc.<sep>sloan-kettering institute for cancer research<sep>newport pharmaceuticals international, inc.1590 monrovia boulevardnewport beach californiaus<sep>sloan-kettering institute for cancer research1275 york avenuenew york, new york 10021us<sep>newport pharmaceuticals international, inc.  <sep>sloan-kettering institute for cancer research<sep>
</APPLICANT>
<INVENTOR>
giner-sorolla alfredo<sep>giner-sorolla, alfredo<sep>giner-sorolla, alfredo9 chapel laneriverside, connecticutus<sep>giner-sorolla, alfredo<sep>giner-sorolla, alfredo9 chapel laneriverside, connecticutus<sep>
</INVENTOR>
<ABSTRACT>
there are prepared compounds of the formula    where x is oh, r² is ch₃ and r¹ is alkyl of 1 to 8 carbon  atoms.  the compounds are immunomodulators, have anti­ viral activity and antitumor activity and also are enzyme  inhibitors.  
</ABSTRACT>
</TEXT>
</DOC>
